DZ Bank Knock-Out VRTX/ DE000DJ6Y4J8 /
31/07/2024 13:34:53 | Chg.+0.700 | Bid13:50:32 | Ask13:50:32 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
13.190EUR | +5.60% | 13.510 Bid Size: 15,000 |
13.650 Ask Size: 15,000 |
Vertex Pharmaceutica... | 367.9258 USD | 31/12/2078 | Call |
GlobeNewswire
28/06
Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Di...
GlobeNewswire
10/06
Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as C...
GlobeNewswire
15/05
Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
09/05
CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference
GlobeNewswire
08/05
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
08/05
CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo ...
GlobeNewswire
07/05
Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
30/04
American Kidney Fund Encourages People to Be APOL1 Aware with First Annual APOL1-Mediated Kidney Dis...
GlobeNewswire
27/04
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLC Investigates MODN, AIRC, INRD, ALPN
GlobeNewswire
22/04
TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUS...
GlobeNewswire
22/04
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASG...
GlobeNewswire
09/04
American Kidney Fund and Alonzo Mourning Call for More Awareness and Understanding of APOL1-Mediated...